Statistics for RxSight, (id:6527 RXST)

Valuation metrics

Market cap

1.82B

Enterprise value

1.59B

Trailing P/E (ttm)

-31.78

Forward P/E

-91.94

PEG ratio

-91.94

Price/Sales (ttm)

14.15

Price/Book (mrq)

6.54

Enterprise Value/Revenue

12.39

Enterprise Value/EBITDA

-45.46

Overview

Shares outstanding

40.30M

Float

34.63M

Shares short

2.74M

% Held by insiders

0.05%

% Held by institutions

0.90%

Average volume (10 days)

989.99K

Average volume (90 days)

Price summary

52-Week low

28.12

52-Week high

66.54

52-Week change

36.33%

Beta

1.19

50-Day moving average

50.32

200-Day moving average

52.83

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-23.92%

Operating margin

-26.13%

Operational effectiveness

Return on assets

-9.92%

Return on equity

-13.99%

Income statement

Revenue (ttm)

3.40

Revenue per share (ttm)

3.40

Quarterly revenue growth (yoy)

Gross profit (ttm)

53.76M

EBITDA

-34,971,000.00

Net income to common (ttm)

-30,694,000.00

Diluted EPS (ttm)

-0.81

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

237.12M

Total cash per share (mrq)

5.88

Total debt (mrq)

11.30M

Total Debt/Equity (mrq)

4.08

Current ratio (mrq)

1.27K%

Book value per share (mrq)

6.89

Cash flow

Cash flow statement

-20,987,000.00

Levered free cash flow (LFCF)

-13,304,750.00